Showing results (71-80 of 144) with videos related to
Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenationBrian D Kavanagh, Timothy W Secomb, Richard Hsu, et al.Health Services Research|September 1, 2017
Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?Aileen B Chen, Ling Li, Angel M Cronin, et al.Urologic Oncology|August 25, 2014
Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancerChad G Rusthoven, Timothy V Waxweiler, Peter E DeWitt, et al.International Journal of Radiation Oncology, Biology, Physics|August 15, 2006
Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasisJoseph M Baisden, Andrew G Reish, Ke Sheng, et al.Acta Oncologica (Stockholm, Sweden)|April 18, 2009
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysisKyle E Rusthoven, Susan F Hammerman, Brian D Kavanagh, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 17, 2010
Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinomaHiginia R Cárdenes, Tracy R Price, Susan M Perkins, et al.Brachytherapy|January 31, 2016
Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data BaseArya Amini, Bernard L Jones, Matthew W Jackson, et al.International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomasAmanda L Schwer, Denise M Damek, Brian D Kavanagh, et al.International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529Jeffrey R Olsen, Jennifer Moughan, Robert Myerson, et al.The Journal of Urology|November 19, 2015
Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data BaseArya Amini, Bernard Jones, Matthew W Jackson, et al.Pageof 15